Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GeneDx Holdings (WGSWW) Other Non Operating Income (2020 - 2025)

GeneDx Holdings has reported Other Non Operating Income over the past 6 years, most recently at -$4.6 million for Q4 2025.

  • Quarterly results put Other Non Operating Income at -$4.6 million for Q4 2025, down 543.0% from a year ago — trailing twelve months through Dec 2025 was -$4.3 million (up 66.83% YoY), and the annual figure for FY2025 was -$4.3 million, up 66.83%.
  • Other Non Operating Income for Q4 2025 was -$4.6 million at GeneDx Holdings, down from -$174000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for WGSWW hit a ceiling of $5.6 million in Q1 2021 and a floor of -$13.5 million in Q2 2024.
  • Median Other Non Operating Income over the past 5 years was $19500.0 (2022), compared with a mean of -$585611.1.
  • Biggest five-year swings in Other Non Operating Income: crashed 56800.0% in 2023 and later soared 464.86% in 2025.
  • GeneDx Holdings' Other Non Operating Income stood at $50000.0 in 2021, then tumbled by 102.0% to -$1000.0 in 2022, then plummeted by 4800.0% to -$49000.0 in 2023, then tumbled by 1357.14% to -$714000.0 in 2024, then plummeted by 543.0% to -$4.6 million in 2025.
  • The last three reported values for Other Non Operating Income were -$4.6 million (Q4 2025), -$174000.0 (Q3 2025), and $239000.0 (Q2 2025) per Business Quant data.